Page last updated: 2024-09-05

sb 203580 and du-21220

sb 203580 has been researched along with du-21220 in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (du-21220)	Trials (du-21220)	Recent Studies (post-2010) (du-21220)
3,489	4	1,137	994	153	101

Protein Interaction Comparison

Protein	Taxonomy	sb 203580 (IC50)	du-21220 (IC50)
Beta-2 adrenergic receptor	Rattus norvegicus (Norway rat)		0.024

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hakariya, T; Igawa, T; Kanetake, H; Sakai, H; Shida, Y	1

Other Studies

1 other study(ies) available for sb 203580 and du-21220

Article	Year
p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion. Biochemical and biophysical research communications, 2007, Feb-16, Volume: 353, Issue:3 Topics: Androgens; Anthracenes; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Interleukin-6; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Pyridines; Ritodrine	2007

Article

Year

p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion.

Biochemical and biophysical research communications, 2007, Feb-16, Volume: 353, Issue:3

Topics: Androgens; Anthracenes; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; Interleukin-6; Male; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Pyridines; Ritodrine

2007